U.S., June 18 -- ClinicalTrials.gov registry received information related to the study (NCT07654751) titled 'A Study to Assess Concentration of TREMFYA in Breast Milk of Lactating Women Who Are Receiving TREMFYA Therapeutically' on June 12.
Brief Summary: The purpose of this post-marketing study is to assess the amount of guselkumab in breast milk of lactating women receiving guselkumab as part of their standard clinical care provided by their treating physician, for any of the approved indications.
Study Start Date: June 15
Study Type: INTERVENTIONAL
Condition:
Psoriasis
Colitis, Ulcerative
Crohn Disease
Arthritis, Psoriatic
Intervention:
PROCEDURE: Breast Milk Sample Collection
Breast milk samples will be collected as per the sche...